JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Equities
002223
CNE1000009X3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.04 CNY | +4.45% |
|
+1.17% | +10.01% |
| Jun. 07 | Yuyue Medical Denies Reports of Controller's Involvement in Corruption Probe | MT |
| Jun. 06 | Yuyue Medical Owners Prohibited from Leaving China for Alleged Links to Baiyao Corruption Case | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 20,370 | 28,280 | 37,427 | 31,529 | 34,221 | 38,116 | - | - |
| Enterprise Value (EV) 1 | 18,957 | 28,280 | 37,427 | 31,529 | 34,221 | 38,116 | 38,116 | 38,116 |
| P/E ratio | 27.1 x | 16.1 x | 25.4 x | 19.8 x | 14.3 x | 17.1 x | 14.9 x | 12.9 x |
| Yield | 1.97% | 1.06% | 0.79% | 1.88% | 2.31% | 1.85% | 1.85% | 2.14% |
| Capitalization / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.36 x | 3.76 x | 3.36 x |
| EV / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.36 x | 3.76 x | 3.36 x |
| EV / EBITDA | 21.1 x | 12.7 x | 19.5 x | 15.2 x | 10.9 x | 14.6 x | 12.8 x | 11.1 x |
| EV / FCF | 116,866,821 x | 13,134,419 x | 40,819,814 x | - | - | - | - | - |
| FCF Yield | 0% | 0% | 0% | - | - | - | - | - |
| Price to Book | 3.36 x | 3.8 x | 4.58 x | 3.24 x | 2.95 x | 2.84 x | 2.46 x | 2.15 x |
| Nbr of stocks (in thousands) | 1,002,477 | 1,002,477 | 990,127 | 989,625 | 989,625 | 1,002,004 | - | - |
| Reference price 2 | 20.32 | 28.21 | 37.80 | 31.86 | 34.58 | 38.04 | 38.04 | 38.04 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,636 | 6,726 | 6,894 | 7,102 | 7,972 | 8,751 | 10,130 | 11,338 |
| EBITDA 1 | 966.9 | 2,224 | 1,917 | 2,079 | 3,131 | 2,616 | 2,986 | 3,430 |
| EBIT 1 | 849.9 | 2,010 | 1,688 | 1,842 | 2,893 | 2,641 | 3,029 | 3,484 |
| Operating Margin | 18.33% | 29.88% | 24.48% | 25.93% | 36.3% | 30.17% | 29.9% | 30.73% |
| Earnings before Tax (EBT) 1 | 864.3 | 2,019 | 1,702 | 1,842 | 2,849 | 2,635 | 3,021 | 3,470 |
| Net income 1 | 752.6 | 1,759 | 1,482 | 1,595 | 2,396 | 2,224 | 2,550 | 2,954 |
| Net margin | 16.23% | 26.15% | 21.5% | 22.46% | 30.05% | 25.41% | 25.18% | 26.06% |
| EPS 2 | 0.7500 | 1.750 | 1.490 | 1.610 | 2.410 | 2.218 | 2.545 | 2.948 |
| Free Cash Flow | 174.3 | 2,153 | 916.9 | - | - | - | - | - |
| FCF margin | 3.76% | 32.01% | 13.3% | - | - | - | - | - |
| FCF Conversion (EBITDA) | 18.03% | 96.83% | 47.84% | - | - | - | - | - |
| FCF Conversion (Net income) | 23.16% | 122.4% | 61.85% | - | - | - | - | - |
| Dividend per Share 2 | 0.4000 | 0.3000 | 0.3000 | 0.6000 | 0.8000 | 0.7050 | 0.7020 | 0.8150 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,277 | 1,683 | 1,309 | 2,231 | 2,282 | 2,060 | 2,616 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | 713.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | 0.7186 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/28/23 | 8/28/23 | 10/24/23 | 4/26/24 | 4/26/24 | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 1,413 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | 174 | 2,153 | 917 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 13.1% | 26.2% | 19.2% | 17.5% | 22.5% | 16.8% | 16.8% | 16.8% |
| ROA (Net income/ Total Assets) | 10% | 19.5% | 13.4% | 11.8% | 15.4% | 13.2% | 12.8% | 13.6% |
| Assets 1 | 7,495 | 9,015 | 11,032 | 13,547 | 15,531 | 16,913 | 19,874 | 21,723 |
| Book Value Per Share 2 | 6.060 | 7.420 | 8.250 | 9.840 | 11.70 | 13.40 | 15.50 | 17.70 |
| Cash Flow per Share 2 | 0.6100 | 2.820 | 1.200 | 2.300 | 2.120 | 1.990 | 2.440 | 2.800 |
| Capex 1 | 440 | 678 | 284 | 178 | 133 | 186 | 271 | 257 |
| Capex / Sales | 9.49% | 10.08% | 4.11% | 2.5% | 1.66% | 2.12% | 2.68% | 2.26% |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
38.04
CNY
Average target price
47.38
CNY
Spread / Average Target
+24.57%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.01% | 5.24B | |
| +75.69% | 12.57B | |
| -28.01% | 7.02B | |
| -18.23% | 4.76B | |
| +15.57% | 4.11B | |
| -20.85% | 3.74B | |
| -20.84% | 2.99B | |
| -1.24% | 2B | |
| +12.39% | 1.81B | |
| -4.11% | 1.72B |
- Stock Market
- Equities
- 002223 Stock
- Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
